-+ 0.00%
-+ 0.00%
-+ 0.00%

DataMeds AI Signs Nonbinding Deal to License and Acquire Healthcare IP

PUBT·10/26/2026 21:02:21
Listen to the news
DataMeds AI Signs Nonbinding Deal to License and Acquire Healthcare IP
  • DataMeds AI entered a nonbinding agreement dated October 19, 2026, to acquire and license healthcare intellectual property.
  • Proposed acquisitions cover EOS and Scilex patents for biometric medication delivery verification and wearable-based monitoring of drug effects.
  • Expanded exclusive licenses from Datavault AI and Data Health Partners would support healthcare data management and patient-outcome tracking.
  • Closing is targeted for the fourth quarter of 2026, subject to definitive agreements, due diligence and Nasdaq requirements.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DataMeds AI Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-048573), on October 26, 2026, and is solely responsible for the information contained therein.